Joep H.M. van Esch

Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels

Mariëtte H.W. Kappers, Joep H.M. van Esch, Wim J. Sluiter et al. · Hypertension · 2010 · 283 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System

Mariëtte H.W. Kappers, Frank Smedts, T. Horn et al. · Hypertension · 2011 · 135 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression

Mariëtte H.W. Kappers, Joep H.M. van Esch, Frank Smedts et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 103 citations

Medicine, Endocrinology, Pharmacology +17

Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib

Stephanie Lankhorst, Mariëtte H.W. Kappers, Joep H.M. van Esch et al. · Hypertension · 2014 · 91 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts

Joep H.M. van Esch, Florian Gembardt, Anja Sterner‐Kock et al. · Cardiovascular Research · 2010 · 79 citations · Full text

Life Sciences, Cardiology, Physiology +16